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The EC-IC Bypass Study: Does it Answer the Question? 
The procedure of cerebral revascularization was inttoduced to the management of patients with cerebrovascular oc-
clusive disease as a surgical option. Cerebral revascularization 
is intended to reestablish cerebral perfusion to brain areas which 
may be deficient in blood flow because of proximal arterial oc-
clusive lesions. These lesions are not accessible by any other 
surgical approach. 
Cerebral revascularization was introduced in 1967 by Yasargil 
and Donaghy (1), and many operations have since been per-
formed. An intemational cooperative study (2,3) was designed 
to determine whether the anastomosis of an extracranial to an 
inttacranial artery (superficial temporal to middle cerebral ar-
tery STA-MCA) would be effective in reducing the development 
of cerebral infarction or death in patients with otherwise inac-
cessible carotid circulation lesions. Patients who had been 
symptomatic within three months before evaluation and who 
had angiographically demonsttable lesions in the appropriate lo-
cation were entered and randomized into either a medical group 
receiving acetylsalicylic acid 325 mg four times a day through-
out the trial or a surgical group undergoing an STA-MCA anas-
tomosis in addition to the medication. A careful foUow-up was 
completed for all these patients, and a commendable statistical 
study was performed on the results. 
The international cooperative study (2,3) found no demon-
strable difference in the development of sttoke or death in pa-
tients treated either medically or surgically. In fact, in patients 
with unilateral intemal carotid artery occlusion or with middle 
cerebral artery stenosis, the patients in the surgical group had a 
worse outcome. Conclusions of the study were: "...fatal and 
nonfatal sttokes were not prevented by anastomosis ofthe super-
ficial temporal to the middle cerebral artery... This negative re-
sult held for all patients and for individual subgroups, whether 
the patients had transient ischemic attacks or minor strokes, 
whether their lesions were occlusive or stenotic, and whether 
they involved the intemal carotid artery, the middle cerebral ar-
tery or both." 
The only scientific conclusion that can be made from the hy-
pothesis tested in the extracranial-inttacranial bypass study is as 
follows: EC-IC bypass surgery, primarily superficial temporal 
to middle cerebral artery anastomosis, was not shown to reduce 
sttoke or sttoke-related deaths more than the aspirin prescribed 
for the population of patients selected, who were evaluated in the 
manner detailed and analyzed with the methods described in the 
study. No valid scientific conclusion can be made that the study 
definitely proves bypass surgery to be of no value because the 
hypothesis did not test that in the study. 
We do not believe that the EC/IC bypass study has been spe-
cific enough to answer whether cerebral revascularization by 
anastomosis ofthe superficial temporal artery to middle cerebral 
artery effectively prevents cerebral infarction or death in pa-
tients with a demonsttated perfusion deficit referable to a spe-
cific territory in the carotid circulation and who have an area of 
inactive but viable cerebral tissue. Evidence from the study 
would suggest that it contained a large percentage, probably 
over 40% of its patients who in fact did not have a blood flow 
deficit to the brain and who had no need for tiie surgery. Propo-
nents of the study will argue that the study was based on the 
methods of selection used by neurosurgeons who have pub-
lished articles on the procedure claiming its benefit. This is tine 
but relates to published work done in the past ten years. It does 
not reflect the changing practice of those accomplished in the 
procedure who no longer follow the indications upon which this 
study was initially based. At present, these criteria have matured 
to select those patients who are clinically unstable with continu-
ing evidence of cerebral ischemia, with evidence of impaired 
collateral circulation to the brain by examination of all the blood 
vessels supplying the brain with four vessel cerebral angiogra-
phy (the study required only two major vessels to be studied) 
and by evaluation and selection of patients on the basis of cere-
bral blood flow testing. 
The pathophysiological mechanisms responsible for the de-
velopment of cerebral ischemia include: 1) an embolic process 
from a distant source with the passage of artery to artery emboli 
and the occlusion of a cerebral vessel, 2) a regional cerebral per-
fusion deficit that results from the existence of a proximal ar-
terial occlusion or a hemodynamically significant stenosis, and 
3) a local cerebral perfusion deficit secondary to the occlusion of 
a small inttaparenchymal cerebral artery. Of these mechanisms, 
the only one that could benefit from the procedure of cerebral 
revascularization by an extracranial to intracranial anastomosis 
is the perfusion deficit that results from a major proximal oc-
clusive arterial lesion. Furthermore, not all proximal occlusive 
lesions result in a perfusion deficit, and not all areas with de-
creased cerebral perfusion have viable tissue that would benefit 
from a cerebral reconstmctive vascular procedure. The meth-
odology in the EC/IC bypass study did not provide a means of 
selection or separation of patients with a perfusion deficit who 
have inactive yet viable tissue. Furthermore, the EC/IC bypass 
study methods did not require full evaluation of coUateral cir-
culation in patients entered in the smdy. The group reported that 
" . . . bilateral common carotid arteriograms have been requested 
on all patients, and angiography of the vertebrobasilar circula-
tion has been optional" (3). Full understanding of the collateral 
circulation to the area of occlusive disease cannot be gained 
without a selective four-vessel cerebral angiogram. 
The conttol group was treated with acetylsalicylic acid and 
compared to the surgical group. The choice of medical treatment 
was based on the findings of the Canadian Cooperative Study 
Group (4), who compared the effect of aspirin, sulfinpyrazone, 
and aspirin and sulfinpyrazone and placebo in patients who by 
clinical criteria alone " . . . had experienced at least one cerebral 
or retinal ischemic attack in the three months before entry." 
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They reported a 19% reduction in the incidence of stroke or 
sttoke-related deaths in a population tteated with acetylsalicylic 
acid 350 mg four times a day. The treatment was beneficial only 
in men. When the four groups were analyzed individually, no 
sufficient number of patients in any group benefited from the 
tteatment to make a statistically valid conclusion. To gain statis-
tical value, those patients tteated with aspirin alone and those 
with aspirin and sulfinpyrazone were added, assuming that sul-
finpyrazone had no effect whatsoever on the tteatment. Neither 
the source of the symptoms nor the benefit of aspirin alone in 
iv^ ducing the incidence of sttoke or sttoke-related death in this 
population were demonsttated. 
Other aspirin studies have shown conflicting results. The 
American, Italian, and Danish studies (5-7) showed no benefit 
for patients treated with aspirin. The French aspirin study (8), 
which included both men and women, found a benefit for pa-
tients tteated with aspirin. The benefit of aspirin in managing 
patients with cerebral ischemic symptoms referable to specific 
angiographic lesions in the carotid circulation has not been 
demonsttated. 
Three major premises in the EC/IC bypass study used to es-
tablish its statistical validity were " . . . a large number of patients 
with a long period of follow-up,... a uniformity of disease pro-
cess in the population studied,... and... the achievement of ef-
fective anastomoses " The large number of patients was 
reached through the collection of cases throughout the world 
from 71 centers. An unproven assumption is that all people from 
different parts of the world can be considered to have the same 
behavior and can be treated equally when dealing with cere-
brovascular occlusive disease. Furthermore, not all 71 centers 
contributed the patients whom they saw to this study and thus a 
certain preselection process occuned, leaving the study to eval-
uate a prescreened population of patients. Evidence from two of 
the 71 centers involved alone indicates that over 90 patients in 
those two centers were not included in the study. Since we could 
not enter all of our patients in a consistent manner, we withdrew 
early from the study. 
Five groups or pattems of atherosclerotic carotid arterial dis-
ease were observed initially in the EC/IC bypass study: "iso-
lated MCA stenosis, isolated MCA occlusion, isolated ICA ste-
nosis (surgically inaccessible), isolated ICA occlusion, and 
tandem lesions." When these groups were preserved as initially 
presented, only the group with unilateral intemal carotid artery 
occlusion had enough numbers to reach statistical power. In the 
group's final report, the tandem lesion group was not mentioned, 
and the numbers in all groups excluding the intemal carotid ar-
tery occlusion group were all different. Reported in the meth-
odology was "when tandem lesions (two lesions in the same 
vessel or sequence of vessels, one proximal to the other) have 
existed, and both lesions have fulfilled entry criteria, the patient 
has been entered for the most distal lesion" (3). Apparently, the 
patients initially reported in the tandem group were later reallo-
cated to the other groups based on the most distal lesion. Even 
though this may be a statistically valid maneuver through which 
all groups were brought to have enough numbers to reach statis-
tical power, the assumption must be made for scientific accep-
tibility that patients with a single lesion have the same patho-
physiological behavior as those patients with tandem lesions. 
When these groups are combined, one can no longer assume that 
the groups are uniform because other factors such as embolic 
phenomena would not be equaUy distributed. 
The achievement of effective anastomoses was determined by 
a postoperative angiogram obtained "three to six months fol-
lowing bypass." However, the final functional status of the pa-
tients at the end of the study was not determined until five years 
later This method assumes that the angiographic observations 
made at the postoperative angiogram in the surgical group and in 
the initial angiogram in the medical group have remained un-
changed. Cerebrovascular occlusive disease is a dynamic pro-
cess that caimot be expected to remain unchanged throughout 
time. The final functional outcome, therefore, cannot be cone-
lated with earlier angiographic procedures. Possibly other inter-
vening occlusive events, different from those originally ob-
served, developed in the interim. Without angiographic 
conelation at the time of final evaluation, one cannot reach a 
cause and effect conclusion. 
The paper by Robertson et al (9) in this issue points out the 
changes observed in a select population of patients with cerebral 
ischemic events with full angiographic evaluation and with cere-
bral blood flow studies. The authors conclude that in this popu-
lation " . . .STA-MCA bypass surgery is effective in increasing 
CBF in a focal area of maximal ischemia." 
It is unknown whether cerebral revascularization by anas-
tomosis of the superficial temporal artery to the middle cerebral 
artery prevents cerebral infarction or death in patients with a 
demonsttated cerebral perfusion deficit and with viable residual 
cerebral tissue in the area of ischemia. A randomized study must 
be conducted to identify persons among the population with ce-
rebral ischemic symptoms who have both a perfusion deficit and 
preserved cerebral tissue. The random allocation to a surgical 
and medical group with adequate follow-up by clinical, an-
giographic, blood flow, and metabolic criteria would then allow 
one to determine the value of EC/IC bypass. Until then, the EC/ 
IC bypass smdy indicates that not all patients seen in the daily 
clinical practice who have a unilateral intemal carotid or middle 
cerebral artery occlusive lesion should be subjected to cerebral 
revascularization. However, the EC/IC bypass study does not yet 
exclude the value of cerebral revascularization for patients with a 
focal cerebral perfusion deficit associated with viable cerebral 
tissue. Furthermore, the findings of the EC/IC bypass study can-
not be generalized to other bypass procedures such as proximal 
MCA anastomosis or posterior fossa revascularization. 
Fernando G. Diaz, MD, PhD 
James I . Ausman, MD, PhD 
Department of Neurosurgery 
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